The current hullabaloo about new recommendations to delay the use of mammograms and Pap smears is just part of a huge debate afoot in the medical establishment about the value of cancer screening tests in general-mammography, PSA, Pap Test, CT Scan, etc.
There is widening concern that too often false-positives result or non-threatening tumours may be discovered, leading to more costly, invasive testing, unnecessary toxic treatment and undue stress.
Are mammograms and Pap smears effective?
What is a responsible medical consumer supposed to do?
F.A.C.T. ‘s position has always been that these tests are too invasive, too often inaccurate, too expensive and far too limited in scope to be of any real value because we view cancer as a systemic disease. It’s not just about the tumour or cancer cells, we believe it is more logical to focus on detecting and correcting any imbalance in the body chemistry that could be the cause of abnormal cell production.
This is why we have long recommended the Human Chorionic Gonadotrophin (HCG) Urine Immunoassay, developed in 1957 by Manual Navarro, M.D. and used successfully by many cancer patients on a bio repair program for early detection and to monitor their progress.
To learn more about the scientific basis and purpose of this test, including easy instructions for individuals to prepare a sample for quantitative analysis, read this:
Are mammograms and Pap smears effective? : HCG Test — A Non-Invasive Diagnostic for Cancer (downloadable pdf)